Covered recipient · General Payments record
MICHAEL T RUK
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$2,769.83
- Reported across 155 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $294.96 | 15 |
| Education | $26.70 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sumitomo Pharma America, Inc. | $90.73 | 4 |
| MILLICENT US INC | $80.24 | 4 |
| Organon LLC | $56.33 | 3 |
| Sage Therapeutics, Inc. | $37.01 | 2 |
| PFIZER INC. | $25.53 | 1 |
| Exeltis, USA Inc. | $17.61 | 1 |
| Exact Sciences Corporation | $14.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Exact Sciences Corporation | $14.21 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114864720 | CMS |
| Exeltis, USA Inc. | $17.61 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150003536 | CMS |
| MILLICENT US INC | $17.59 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150911576 | CMS |
| MILLICENT US INC | $17.50 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150911578 | CMS |
| MILLICENT US INC | $26.70 | 07/18/2024 | Education | Undisputed | 01/23/2026 | 1150911580 | CMS |
| MILLICENT US INC | $18.45 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150911582 | CMS |
| Organon Llc | $20.45 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136192317 | CMS |
| Organon Llc | $22.05 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136192315 | CMS |
| Organon Llc | $13.83 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136192319 | CMS |
| PFIZER INC. | $25.53 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132055734 | CMS |
| Sage Therapeutics, Inc. | $20.41 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120404262 | CMS |
| Sage Therapeutics, Inc. | $16.60 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120409615 | CMS |
| Sumitomo Pharma America, Inc. | $25.67 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148912652 | CMS |
| Sumitomo Pharma America, Inc. | $23.20 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148912654 | CMS |
| Sumitomo Pharma America, Inc. | $20.86 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148912656 | CMS |
| Sumitomo Pharma America, Inc. | $21.00 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148912658 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.